BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22449736)

  • 1. Insulin resistance: a significant risk factor of endometrial cancer.
    Mu N; Zhu Y; Wang Y; Zhang H; Xue F
    Gynecol Oncol; 2012 Jun; 125(3):751-7. PubMed ID: 22449736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects.
    Ashizawa N; Yahata T; Quan J; Adachi S; Yoshihara K; Tanaka K
    Gynecol Oncol; 2010 Oct; 119(1):65-9. PubMed ID: 20674961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between adiponectin, insulin resistance, and endometrial cancer.
    Soliman PT; Wu D; Tortolero-Luna G; Schmeler KM; Slomovitz BM; Bray MS; Gershenson DM; Lu KH
    Cancer; 2006 Jun; 106(11):2376-81. PubMed ID: 16639730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Energy balance, physical activity, and cancer risk.
    Fair AM; Montgomery K
    Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acrp30 inhibits leptin-induced metastasis by downregulating the JAK/STAT3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells.
    Wu X; Yan Q; Zhang Z; Du G; Wan X
    Oncol Rep; 2012 May; 27(5):1488-96. PubMed ID: 22327423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity, type 2 diabetes and risk of digestive cancer.
    Hillon P; Guiu B; Vincent J; Petit JM
    Gastroenterol Clin Biol; 2010 Oct; 34(10):529-33. PubMed ID: 20864282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.
    Kaaks R; Lukanova A; Kurzer MS
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1531-43. PubMed ID: 12496040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of genetic alterations in human endometrial cancer and melanoma: distinct tumorigenic pathways that share a frequent abnormal PI3K/AKT cascade.
    Ogawa K; Sun C; Horii A
    Oncol Rep; 2005 Dec; 14(6):1481-5. PubMed ID: 16273242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to chemotherapy and hormone therapy in endometrial cancer.
    Chaudhry P; Asselin E
    Endocr Relat Cancer; 2009 Jun; 16(2):363-80. PubMed ID: 19190080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation.
    Catalano S; Giordano C; Rizza P; Gu G; Barone I; Bonofiglio D; Giordano F; Malivindi R; Gaccione D; Lanzino M; De Amicis F; Andò S
    J Cell Physiol; 2009 Mar; 218(3):490-500. PubMed ID: 18988190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity, adipocytokines, and insulin resistance in breast cancer.
    Rose DP; Komninou D; Stephenson GD
    Obes Rev; 2004 Aug; 5(3):153-65. PubMed ID: 15245384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity.
    Dyck DJ; Heigenhauser GJ; Bruce CR
    Acta Physiol (Oxf); 2006 Jan; 186(1):5-16. PubMed ID: 16497175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between plasma adiponectin levels and metabolic risk profiles in Taiwanese children.
    Chu NF; Shen MH; Wu DM; Lai CJ
    Obes Res; 2005 Nov; 13(11):2014-20. PubMed ID: 16339134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2.
    Cong L; Gasser J; Zhao J; Yang B; Li F; Zhao AZ
    Endocr Relat Cancer; 2007 Sep; 14(3):713-20. PubMed ID: 17914101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitogenic and anti-apoptotic effects of insulin in endometrial cancer are phosphatidylinositol 3-kinase/Akt dependent.
    Wang Y; Hua S; Tian W; Zhang L; Zhao J; Zhang H; Zhang W; Xue F
    Gynecol Oncol; 2012 Jun; 125(3):734-41. PubMed ID: 22426488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [OBESITY AND ENDOMETRIAL CARCINOGENESIS].
    Uchikova E; Uchikov P; Parahuleva P
    Akush Ginekol (Sofiia); 2015; 54(9):34-7. PubMed ID: 26863794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C alpha expression is inversely related to ER status in endometrial carcinoma: possible role in AP-1-mediated proliferation of ER-negative endometrial cancer.
    Fournier DB; Chisamore M; Lurain JR; Rademaker AW; Jordan VC; Tonetti DA
    Gynecol Oncol; 2001 Jun; 81(3):366-72. PubMed ID: 11371124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study.
    Lacey JV; Potischman N; Madigan MP; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Lurain JR; Fillmore CM; Sherman ME; Brinton LA
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):607-12. PubMed ID: 15066926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.